Recent Updates
Recently added Catalysts
LFCR Positive Sentiment Score: 75/100

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Key Takeaway: Lifecore Biomedical, Inc. will participate in the CDMO Live 2025 conference scheduled for May 7-8, 2025, in Rotterdam, Netherlands. Executive Vice President Jackie Klecker will chair a discussion on improving quality management within CDMO partnerships. The event aims to address how quality can drive success in the biopharma outsourcing industry. Lifecore, a fully integrated contract development and manufacturing organization, specializes in sterile injectable pharmaceutical products.

Market Sentiment Analysis

POSITIVE FACTORS

  • Lifecore's participation in CDMO Live highlights its active role in the industry.
  • Jackie Klecker's leadership reflects the company's strong expertise in quality management.
  • The conference focuses on strategic advancements in quality management for CDMO partnerships.

Full Press Release Details

CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO Live 2025 conference. Billed as a premiere partnering event for the biopharma outsourcing industry, CDMO Live will take place May 7-8, 2025, in Rotterdam, Netherlands.
During the conference, Jackie Klecker, Lifecore’s executive vice president, quality and development services, will chair a discussion featuring external quality leaders from the CDMO industry. The talk will explore approaches for transforming quality management from a potential bottleneck into a strategic driver of CDMO partnerships. Ms. Klecker is well-positioned to lead the discussion based on her more than 30 years of industry experience in quality, manufacturing, and development, including guiding Lifecore’s quality assurance for over a decade.
Details regarding the discussion are as follows:
Quality as a Catalyst: Accelerating CDMO Success Through Quality Management
Chaired by Jackie Klecker, executive vice president, quality and development services, Lifecore Biomedical
Wednesday, May 7, 2025, Noon local time in Rotterdam
To learn more about the CDMO Live 2025 conference, please visit: https://pharmasource.global/events/cdmolive/
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Tags

contract manufacturing

Frequently Asked Questions

What event will Lifecore Biomedical participate in?

Lifecore Biomedical will participate in the CDMO Live 2025 conference.

Who will chair the discussion at CDMO Live 2025?

Jackie Klecker will chair the discussion at CDMO Live 2025.

When is the CDMO Live 2025 conference scheduled?

The conference will take place on May 7-8, 2025.

What is Lifecore Biomedical known for?

Lifecore is known for contract development and manufacturing of sterile injectables.

Where will the CDMO Live 2025 event take place?

The event will be held in Rotterdam, Netherlands.

Last updated: Apr 22, 2025